Stay updated with breaking news from Ameet nathwani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer - Sendek adds 30 years experience in biotechnology leadership News provided by Share this article Share this article BOSTON, Feb. 11, 2021 /PRNewswire/ Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Joel Sendek as Chief Financial Officer and Treasurer. As we accelerate our growth plans, Joel s financial expertise and leadership in fundraising and corporate finance for both private and public biotech companies will be invaluable, said Ameet Nathwani, M.D., Chief Executive Officer of Dewpoint Therapeutics. I am delighted to welcome him to our rapidly growing team and look forward to the significant contributions he will make as we work to leverage biomolecular condensates to create medicines for some of the world s toughest diseases. ....